Privium Fund Management B.V.
AMSTERDAM, P7
$544m in 61 US stocks at the end of 30 June 2026. The top 10 are 61.8% of the money. It changed about 18.4% of the portfolio this quarter.
Value
$544m
Stocks
61
Top 10 share
61.8%
Turnover
18.4%
What changed this quarter
New
Bought for the first time this quarter.
- Opendoor TechnologiesOPEN3.3% of the fund
- Cerebras SystemsCBRS2.5% of the fund
- Space Exploration TechnologiesSPCX1.3% of the fund
- Magnum Ice CreamMICC0.3% of the fund
- ZoetisZTS0.2% of the fund
- Legend BiotechLEGN0.2% of the fund
- TotalEnergies SETTE0.1% of the fund
- Nu HoldingsNU0.1% of the fund
- lululemon athleticaLULU0.1% of the fund
- Seabridge GoldSA<0.1% of the fund
- enGene TherapeuticsENGN<0.1% of the fund
- Cosan S ACSANY<0.1% of the fund
Added
Bought more of a stock they already held.
- TeslaTSLA17.6% of the fund+3%
- Amazon.comAMZN6.1% of the fund+12%
- Ionis PharmaceuticalsIONS4.7% of the fund+10%
- LemonadeLMND3.2% of the fund+6%
- IrenIREN2.9% of the fund+6%
- Arcutis BiotherapeuticsARQT1.9% of the fund+24%
- BiogenBIIB1.9% of the fund+11%
- Biontech SEBNTX0.5% of the fund+11%
- Hims & Hers HealthHIMS0.5% of the fund+100%
- Sarepta TherapeuticsSRPT0.5% of the fund+197%
- CRISPR Therapeutics AGCRSP0.5% of the fund+5%
- Beam TherapeuticsBEAM0.4% of the fund+10%
- Taysha Gene TherapiesTSHA0.2% of the fund+9%
- B2goldBTG0.1% of the fund+102%
- TransoceanRIG0.1% of the fund+37%
- TidewaterTDW0.1% of the fund+58%
Cut
Sold some of their stake.
- ShopifySHOP7.8% of the fund-9%
- Spotify TechnologySPOT4.6% of the fund-18%
- Arrowhead PharmaceuticalsARWR3.5% of the fund-36%
- uniQureQURE2.8% of the fund-33%
- Ultragenyx PharmaceuticalRARE2.1% of the fund-7%
- Axsome TherapeuticsAXSM1.8% of the fund-32%
- UroGen PharmaURGN1.4% of the fund-12%
- Denali TherapeuticsDNLI1.1% of the fund-10%
- Vertex PharmaceuticalsVRTX0.9% of the fund-17%
- Biomarin PharmaceuticalBMRN0.8% of the fund-19%
- Alnylam PharmaceuticalsALNY0.6% of the fund-7%
- MeiraGTx HoldingsMGTX0.5% of the fund-8%
- Ambev SAABEV0.5% of the fund-15%
- ZAI LABZLAB0.4% of the fund-8%
- Cartesian TherapeuticsRNAC0.3% of the fund-15%
- 4D Molecular TherapeuticsFDMT0.2% of the fund-47%
- Lexeo TherapeuticsLXEO0.1% of the fund-24%
- Molina HealthcareMOH0.1% of the fund-63%
Sold out
Sold their entire stake.
- Coinbase GlobalCOIN-100%
- SeaSE-100%
- Esperion Therapeutics INC NE-100%
- Engene Holdings-100%
- Stoke TherapeuticsSTOK-100%
- PfizerPFE-100%
- SLB LimitedSLB-100%
- Seabridge GoldSA-100%
- NobleNE-100%
- PAN American SilverPAAS-100%
- Sprott FDS TRURNM-100%
Holdings
- Cerebras SystemsCBRS
- Share
- 2.5%
- Value
- $13m
- Shares
- 60,500
New
- Space Exploration TechnologiesSPCX
- Share
- 1.3%
- Value
- $7m
- Shares
- 40,000
New
- Biontech SEBNTX
- Share
- 0.5%
- Value
- $3m
- Shares
- 30,100
+11%
- Ambev SAABEV
- Share
- 0.5%
- Value
- $3m
- Shares
- 802,167
-15%
- ZAI LABZLAB
- Share
- 0.4%
- Value
- $2m
- Shares
- 122,189
-8%
- Legend BiotechLEGN
- Share
- 0.2%
- Value
- $1m
- Shares
- 35,400
New
- B2goldBTG
- Share
- 0.1%
- Value
- $729,610
- Shares
- 195,083
+102%
- Autolus TherapeuticsAUTL
- Share
- 0.1%
- Value
- $581,488
- Shares
- 363,430
Held
- Seabridge GoldSA
- Share
- <0.1%
- Value
- $425,019
- Shares
- 16,512
New
- Cosan S ACSANY
- Share
- <0.1%
- Value
- $149,760
- Shares
- 52,000
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| TeslaTSLA | 17.6% | $96m | 228,000 | +3% |
| ShopifySHOP | 7.8% | $42m | 370,000 | -9% |
| Advanced Micro DevicesAMD | 6.6% | $36m | 62,000 | Held |
| Amazon.comAMZN | 6.1% | $33m | 140,000 | +12% |
| Ionis PharmaceuticalsIONS | 4.7% | $25m | 319,924 | +10% |
| Spotify TechnologySPOT | 4.6% | $25m | 55,000 | -18% |
| Palantir TechnologiesPLTR | 4.3% | $23m | 200,000 | Held |
| Arrowhead PharmaceuticalsARWR | 3.5% | $19m | 234,222 | -36% |
| Opendoor TechnologiesOPEN | 3.3% | $18m | 3,940,904 | New |
| LemonadeLMND | 3.2% | $18m | 270,259 | +6% |
| NvidiaNVDA | 3.0% | $16m | 81,000 | Held |
| IrenIREN | 2.9% | $16m | 340,150 | +6% |
| uniQureQURE | 2.8% | $15m | 328,322 | -33% |
| Cerebras SystemsCBRS | 2.5% | $13m | 60,500 | New |
| AST SpaceMobileASTS | 2.4% | $13m | 145,000 | Held |
| Ultragenyx PharmaceuticalRARE | 2.1% | $11m | 338,800 | -7% |
| Arcutis BiotherapeuticsARQT | 1.9% | $10m | 399,367 | +24% |
| BiogenBIIB | 1.9% | $10m | 48,400 | +11% |
| ProQR TherapeuticsPRQR | 1.9% | $10m | 5,520,024 | Held |
| Axsome TherapeuticsAXSM | 1.8% | $10m | 39,944 | -32% |
| UroGen PharmaURGN | 1.4% | $8m | 210,000 | -12% |
| Space Exploration TechnologiesSPCX | 1.3% | $7m | 40,000 | New |
| Denali TherapeuticsDNLI | 1.1% | $6m | 229,857 | -10% |
| Vertex PharmaceuticalsVRTX | 0.9% | $5m | 9,400 | -17% |
| Biomarin PharmaceuticalBMRN | 0.8% | $4m | 75,000 | -19% |
| Krystal BiotechKRYS | 0.8% | $4m | 11,170 | Held |
| Alnylam PharmaceuticalsALNY | 0.6% | $3m | 11,372 | -7% |
| Viridian TherapeuticsVRDN | 0.6% | $3m | 173,516 | Held |
| Biontech SEBNTX | 0.5% | $3m | 30,100 | +11% |
| Hims & Hers HealthHIMS | 0.5% | $3m | 80,000 | +100% |
| MeiraGTx HoldingsMGTX | 0.5% | $3m | 196,112 | -8% |
| Ambev SAABEV | 0.5% | $3m | 802,167 | -15% |
| Sarepta TherapeuticsSRPT | 0.5% | $2m | 136,500 | +197% |
| CRISPR Therapeutics AGCRSP | 0.5% | $2m | 44,974 | +5% |
| Beam TherapeuticsBEAM | 0.4% | $2m | 70,282 | +10% |
| ZAI LABZLAB | 0.4% | $2m | 122,189 | -8% |
| ModernaMRNA | 0.4% | $2m | 29,994 | Held |
| Cartesian TherapeuticsRNAC | 0.3% | $2m | 151,675 | -15% |
| Magnum Ice CreamMICC | 0.3% | $1m | 98,221 | New |
| Wave Life SciencesWVE | 0.3% | $1m | 241,010 | Held |
| Taysha Gene TherapiesTSHA | 0.2% | $1m | 198,900 | +9% |
| ZoetisZTS | 0.2% | $1m | 17,322 | New |
| 4D Molecular TherapeuticsFDMT | 0.2% | $1m | 90,110 | -47% |
| Fate TherapeuticsFATE | 0.2% | $1m | 414,311 | Held |
| Legend BiotechLEGN | 0.2% | $1m | 35,400 | New |
| Rocket PharmaceuticalsRCKT | 0.2% | $834,979 | 244,146 | Held |
| NOVNOV | 0.1% | $779,582 | 42,026 | Held |
| B2goldBTG | 0.1% | $729,610 | 195,083 | +102% |
| TotalEnergies SETTE | 0.1% | $729,486 | 10,723 | New |
| Lexeo TherapeuticsLXEO | 0.1% | $722,300 | 155,000 | -24% |
| TransoceanRIG | 0.1% | $712,004 | 145,604 | +37% |
| Molina HealthcareMOH | 0.1% | $681,297 | 2,979 | -63% |
| Nu HoldingsNU | 0.1% | $587,840 | 44,000 | New |
| Autolus TherapeuticsAUTL | 0.1% | $581,488 | 363,430 | Held |
| TidewaterTDW | 0.1% | $578,548 | 8,683 | +58% |
| lululemon athleticaLULU | 0.1% | $578,093 | 5,063 | New |
| Sandridge EnergySD | <0.1% | $531,450 | 38,792 | Held |
| Seabridge GoldSA | <0.1% | $425,019 | 16,512 | New |
| Voyager TherapeuticsVYGR | <0.1% | $420,000 | 120,000 | Held |
| enGene TherapeuticsENGN | <0.1% | $294,100 | 170,000 | New |
| Cosan S ACSANY | <0.1% | $149,760 | 52,000 | New |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 17.4% since 30 June 2025.
Where the money is
Health care31.4%
Technology25.4%
Retail & consumer23.9%
Media & telecom7.0%
Financial services6.2%
Real estate3.3%
Energy0.5%
Everyday goods0.3%
Materials0.2%
Industrials0.1%
Other1.7%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.